Latest News and Events
Filter by
Selections
October 15, 2018
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-ANG3
Read MoreOctober 11, 2018
Arrowhead to Present Late-Breaking Clinical Data on ARO-AAT and ARO-HBV at AASLD Liver Meeting® 2018
Read MoreOctober 4, 2018
Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen
Read MoreSeptember 25, 2018
Arrowhead Pharmaceuticals to Present at Upcoming October 2018 Conferences
Read MoreSeptember 24, 2018
Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics
Read MoreSeptember 21, 2018
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Read MoreSeptember 6, 2018
Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit
Read MoreAugust 31, 2018